SHERIDAN, WYOMING – May 6, 2025 – Philips has secured one of the design industry’s most coveted honors—the iF Design Gold Award 2025—for its Azurion Neuro Biplane system, marking a significant achievement in the intersection of medical technology and human-centered design. This recognition cements Philips' leadership in image-guided therapy systems and underscores its commitment to enhancing clinical precision, operational efficiency, and patient-centric innovation in healthcare environments worldwide.

SHERIDAN, WYOMING – May 6, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced key updates to its Supervisory Board composition and committee leadership ahead of its Annual General Meeting (AGM) scheduled for May 8, 2025. The adjustments, prompted by recent executive developments, aim to reinforce strategic governance while maintaining alignment with shareholder interests and regulatory best practices.

Strategic Governance Realignment Following CEO Nomination

SHERIDAN, WYOMING – May 6, 2025 – St. Luke’s University Health Network has announced a landmark investment of over $30 million in GE HealthCare’s advanced Magnetic Resonance Imaging (MRI) technology, reinforcing its commitment to cutting-edge diagnostic innovation and enhanced patient care. This strategic move by the Bethlehem, Pennsylvania-based nonprofit healthcare network is aimed at expanding access to faster, more precise imaging while significantly improving patient comfort and operational efficiency.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has reported a strong start to 2025 with notable revenue and profit gains in the first quarter, signaling resilience amid global trade complexities and bolstering its long-term value proposition through innovation and strategic acquisitions.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has announced a strategic expansion of its radiation oncology solutions, unveiling a suite of AI-driven technologies at the ESTRO 2025 Congress in Vienna, Austria. These developments are designed to streamline oncology workflows, accelerate treatment timelines, and improve clinical outcomes—addressing critical priorities in modern cancer care.

SHERIDAN, WYOMING – May 6, 2025 – GE HealthCare (Nasdaq: GEHC) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Aurora dual-head SPECT/CT system and Clarify DL, a Deep Learning-powered image reconstruction solution. This milestone underscores GE HealthCare’s commitment to advancing nuclear medicine by offering solutions that drive diagnostic precision, streamline workflows, and support evolving clinical needs.

SHERIDAN, WYOMING – May 5, 2025 – Siemens Healthineers has introduced its Magnetom Flow RT Pro Edition at the European Society for Radiotherapy and Oncology (ESTRO) 2025, marking a significant innovation in magnetic resonance imaging (MRI) tailored for radiation therapy. Designed for operational flexibility and clinical precision, the 1.5 Tesla system addresses longstanding challenges in integrating MRI within radiation oncology environments while offering sustainability and workflow advantages.

SHERIDAN, WYOMING – May 5, 2025 – Siemens Healthineers and Klinikum Region Hannover (KRH) have jointly launched an advanced Infection Control System (ICS) at KRH Klinikum Siloah, a leading regional hospital in Hannover, Germany. The strategic implementation marks a significant move toward reducing hospital-acquired infections (HAIs), improving hygiene standards, and safeguarding both patient and staff well-being across the facility.

Combatting Nosocomial Infections with Innovation

SHERIDAN, WYOMING – May 5, 2025 – Tower Health and Siemens Healthineers have entered a decade-long Value Partnership designed to modernize diagnostic imaging capabilities, enhance operational efficiency, and support long-term clinical excellence across the Tower Health network. The multi-faceted alliance marks a strategic investment in state-of-the-art technology and digital tools aimed at elevating patient care in radiology, oncology, and cardiology services.

Driving Long-Term Value Through Technological Modernization

SHERIDAN, WYOMING – May 5, 2025 – Johnson & Johnson MedTech has announced encouraging 3-month results from its pivotal Omny-IRE clinical trial, spotlighting the high-performance capabilities of its investigational OMNYPULSE™ Platform.